Hemodynamic predictors of mortality in adults with sickle cell disease.
暂无分享,去创建一个
G. Kato | A. Mehari | R. Machado | O. Castro | V. Sachdev | C. Minniti | X. Tian | P. Adams-Graves | Catherine Seamon | Dihua Xu | James G. Taylor | C. Barnett | M. Cuttica | S. Alam | G. Miles
[1] Horst Olschewski,et al. Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[2] J. Stockman,et al. A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease , 2013 .
[3] M. Gladwin,et al. Mortality in adults with sickle cell disease and pulmonary hypertension. , 2012, JAMA.
[4] G. Simonneau,et al. Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different , 2012, European Respiratory Journal.
[5] V. Salemi,et al. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease , 2011, European Respiratory Journal.
[6] D. Spevack,et al. An Elevated Estimated Pulmonary Arterial Systolic Pressure, Whenever Measured, Is Associated with Excess Mortality in Adults with Sickle Cell Disease , 2011, Acta Haematologica.
[7] R. Hebbel. Reconstructing sickle cell disease: A data‐based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence‐based medicine , 2011, American journal of hematology.
[8] M. Gladwin,et al. Hemodynamic Parameters Predict Mortality In Sickle Cell Disease-Related Pulmonary Hypertension , 2010 .
[9] O. Platt,et al. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. , 2010, Blood.
[10] Christopher S Coffey,et al. Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.
[11] Yutaka Takeda,et al. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension , 2010, BMC pulmonary medicine.
[12] N. Lee,et al. Diagnosis and assessment of pulmonary arterial hypertension , 2010 .
[13] G. Simonneau. [A new clinical classification of pulmonary hypertension]. , 2009, Bulletin de l'Academie nationale de medecine.
[14] G. Kato,et al. Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea , 2009, American journal of hematology.
[15] L. Savale,et al. Prevalence and Mechanism of Pulmonary Hypertension in Sickle Cell Disease: A Prospective Multicentre French Study. , 2009, ATS 2009.
[16] F. Pashankar,et al. Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease , 2009, British journal of haematology.
[17] A. Zaiman,et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. , 2009, Arthritis and rheumatism.
[18] M. Humbert,et al. [Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension]. , 2008, La Revue du praticien.
[19] M. Gladwin,et al. Chronic Hyper-Hemolysis in Sickle Cell Anemia: Association of Vascular Complications and Mortality with Less Frequent Vasoocclusive Pain , 2008, PloS one.
[20] F. Roudot-thoraval,et al. Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease at a Glance Commentary , 2022 .
[21] A. Ashley-Koch,et al. Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes , 2008, American journal of hematology.
[22] M. Gladwin,et al. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency , 2008, American journal of hematology.
[23] G. Simonneau,et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. , 2008, American journal of respiratory and critical care medicine.
[24] M. Cairo,et al. Pulmonary hypertension in sickle cell disease. , 2007, Clinical advances in hematology & oncology : H&O.
[25] Vandana Sachdev,et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. , 2007, American journal of respiratory and critical care medicine.
[26] M. Mosunjac,et al. Sickle Cell Lung Disease and Sudden Death: A Retrospective/Prospective Study of 21 Autopsy Cases and Literature Review , 2007, The American journal of forensic medicine and pathology.
[27] M. Gladwin,et al. PULMONARY HYPERTENSION IN SICKLE CELL DISEASE: Relevance to Children , 2007, Pediatric hematology and oncology.
[28] M. Gladwin,et al. Severity of pulmonary hypertension during vaso‐occlusive pain crisis and exercise in patients with sickle cell disease , 2007, British journal of haematology.
[29] William O Ntim,et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. , 2007, Journal of the American College of Cardiology.
[30] M. Gladwin,et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. , 2006, Circulation.
[31] C. Moore,et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study , 2006, British journal of haematology.
[32] Mark T Gladwin,et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. , 2005, Blood.
[33] S. Kimmel,et al. Hemodynamics and survival of patients with portopulmonary hypertension , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[34] J. Krishnan,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[35] C. Denton,et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach , 2003, Annals of the rheumatic diseases.
[36] Arvind K. Shah,et al. Causes of death in sickle cell disease: an autopsy study , 2003, British journal of haematology.
[37] O. Castro,et al. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. , 2003, Blood.
[38] D. Chemla,et al. Haemodynamic evaluation of pulmonary hypertension , 2002, European Respiratory Journal.
[39] P. Adegboyega,et al. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. , 2002, Human pathology.
[40] A. Shillington,et al. Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy , 2002, Circulation.
[41] Gilles Garcia,et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.
[42] M. Gladwin,et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease , 2002, Nature Medicine.
[43] M. Daly,et al. Guilt by association , 2000, Nature Genetics.
[44] R. Wiesner,et al. Pulmonary hemodynamics and perioperative cardiopulmonary‐related mortality in patients with portopulmonary hypertension undergoing liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[45] Stuart Rich,et al. Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease , 2000, Annals of Internal Medicine.
[46] M. Fujita,et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.
[47] P. Reddy,et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. , 1993, American heart journal.
[48] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[49] N. Schiller,et al. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. , 1990, The American journal of cardiology.
[50] J. Niland,et al. Sickle Cell Chronic Lung Disease: Prior Morbidity and the Risk of Pulmonary Failure , 1988, Medicine.
[51] A. Van Tosh,et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.
[52] G. Guyatt,et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.
[53] E. Orringer,et al. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. , 1982, The American journal of medicine.
[54] D. Wolfe,et al. Nonparametric Statistical Methods. , 1974 .
[55] H. Hellems,et al. Hemodynamic Studies in Sickle Cell Anemia , 1954, Circulation.